Curation
PascalFrancis
Racine
Curation
Checkpoint
PascalFrancis
Racine
PascalFrancis
Exploration
Accueil
Racine
Racine

Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Positive impact of delayed breast reconstruction on breast-cancer treatment-related arm lymphoedema

Identifieur interne : 000876 ( PascalFrancis/Curation ); précédent : 000875; suivant : 000877

Positive impact of delayed breast reconstruction on breast-cancer treatment-related arm lymphoedema

Auteurs : Marie Blanchard [France] ; Maria Arrault [France] ; Stephane Vignes [France]

Source :

RBID : Pascal:12-0305302

Descripteurs français

English descriptors

Abstract

Background: The study aims to determine the impact of delayed breast reconstruction on women with breast-cancer treatment-related lymphoedema after mastectomy. Methods: Twenty women with breast-cancer treatment-related arm lymphoedema prospectively requesting breast reconstruction were included between January 2002 and June 2009. Lymphoedema volume was calculated for each 5-cm segment using the formula for a truncated cone. Results: Three patients underwent transverse rectus abdominis myocutaneous flap reconstruction, five received pedicled latissimus dorsi myocutaneous flaps associated with a breast implant and 12 a breast implant (silicone) alone. Median lymphoedema duration at the time of breast reconstruction was 21 (interquartile range (IQR): 17-34) months. Breast reconstruction was done a median of 30 (IQR: 23-56) months after mastectomy. The median lymphoedema volume at medians of 5 (244 ml, IQR: 159-435) and 22 months (235 ml, IQR: 146-361) of follow-up after reconstruction compared to that measured 6 months before breast reconstruction of 378 ml (IQR: 261-459) were significantly lower (p < 0.02 for both). Specific lymphoedema treatment, unchanged during the study, included manual lymph drainage for all women, elastic sleeves for 19 and low-stretch bandages for 14. Conclusion: Delayed breast reconstruction is feasible for women who have developed lymphoedema after mastectomy for breast cancer. Further studies are needed to compare the different breast-reconstruction techniques and to determine their ideal timing (immediate or delayed).
pA  
A01 01  1    @0 1748-6815
A05       @2 65
A06       @2 8
A08 01  1  ENG  @1 Positive impact of delayed breast reconstruction on breast-cancer treatment-related arm lymphoedema
A11 01  1    @1 BLANCHARD (Marie)
A11 02  1    @1 ARRAULT (Maria)
A11 03  1    @1 VIGNES (Stephane)
A14 01      @1 Department of Lymphology, Hôpital Cognacq-Jay, 15, rue Eugène Millon @2 75015 Paris @3 FRA @Z 1 aut. @Z 2 aut. @Z 3 aut.
A20       @1 1060-1063
A21       @1 2012
A23 01      @0 ENG
A43 01      @1 INIST @2 11042 @5 354000506642430090
A44       @0 0000 @1 © 2012 INIST-CNRS. All rights reserved.
A45       @0 12 ref.
A47 01  1    @0 12-0305302
A60       @1 P
A61       @0 A
A64 01  1    @0 Journal of plastic, reconstructive & aesthetic surgery
A66 01      @0 GBR
C01 01    ENG  @0 Background: The study aims to determine the impact of delayed breast reconstruction on women with breast-cancer treatment-related lymphoedema after mastectomy. Methods: Twenty women with breast-cancer treatment-related arm lymphoedema prospectively requesting breast reconstruction were included between January 2002 and June 2009. Lymphoedema volume was calculated for each 5-cm segment using the formula for a truncated cone. Results: Three patients underwent transverse rectus abdominis myocutaneous flap reconstruction, five received pedicled latissimus dorsi myocutaneous flaps associated with a breast implant and 12 a breast implant (silicone) alone. Median lymphoedema duration at the time of breast reconstruction was 21 (interquartile range (IQR): 17-34) months. Breast reconstruction was done a median of 30 (IQR: 23-56) months after mastectomy. The median lymphoedema volume at medians of 5 (244 ml, IQR: 159-435) and 22 months (235 ml, IQR: 146-361) of follow-up after reconstruction compared to that measured 6 months before breast reconstruction of 378 ml (IQR: 261-459) were significantly lower (p < 0.02 for both). Specific lymphoedema treatment, unchanged during the study, included manual lymph drainage for all women, elastic sleeves for 19 and low-stretch bandages for 14. Conclusion: Delayed breast reconstruction is feasible for women who have developed lymphoedema after mastectomy for breast cancer. Further studies are needed to compare the different breast-reconstruction techniques and to determine their ideal timing (immediate or delayed).
C02 01  X    @0 002B25
C02 02  X    @0 002B20E02
C02 03  X    @0 002B12B04
C03 01  X  FRE  @0 Cancer du sein @2 NM @5 01
C03 01  X  ENG  @0 Breast cancer @2 NM @5 01
C03 01  X  SPA  @0 Cáncer del pecho @2 NM @5 01
C03 02  X  FRE  @0 Lymphoedème @5 02
C03 02  X  ENG  @0 Lymphedema @5 02
C03 02  X  SPA  @0 Linfedema @5 02
C03 03  X  FRE  @0 Plastie @5 04
C03 03  X  ENG  @0 Plasty @5 04
C03 03  X  SPA  @0 Plastia @5 04
C03 04  X  FRE  @0 Traitement @5 05
C03 04  X  ENG  @0 Treatment @5 05
C03 04  X  SPA  @0 Tratamiento @5 05
C03 05  X  FRE  @0 Chirurgie @5 06
C03 05  X  ENG  @0 Surgery @5 06
C03 05  X  SPA  @0 Cirugía @5 06
C03 06  X  FRE  @0 Sein @5 07
C03 06  X  ENG  @0 Breast @5 07
C03 06  X  SPA  @0 Seno @5 07
C03 07  X  FRE  @0 Bras @5 08
C03 07  X  ENG  @0 Arm @5 08
C03 07  X  SPA  @0 Brazo @5 08
C07 01  X  FRE  @0 Tumeur maligne @2 NM @5 37
C07 01  X  ENG  @0 Malignant tumor @2 NM @5 37
C07 01  X  SPA  @0 Tumor maligno @2 NM @5 37
C07 02  X  FRE  @0 Cancer @2 NM
C07 02  X  ENG  @0 Cancer @2 NM
C07 02  X  SPA  @0 Cáncer @2 NM
C07 03  X  FRE  @0 Pathologie de la glande mammaire @2 NM @5 38
C07 03  X  ENG  @0 Mammary gland diseases @2 NM @5 38
C07 03  X  SPA  @0 Glándula mamaria patología @2 NM @5 38
C07 04  X  FRE  @0 Pathologie du sein @2 NM @5 39
C07 04  X  ENG  @0 Breast disease @2 NM @5 39
C07 04  X  SPA  @0 Seno patología @2 NM @5 39
C07 05  X  FRE  @0 Pathologie de l'appareil circulatoire @5 40
C07 05  X  ENG  @0 Cardiovascular disease @5 40
C07 05  X  SPA  @0 Aparato circulatorio patología @5 40
C07 06  X  FRE  @0 Pathologie des vaisseaux lymphatiques @5 41
C07 06  X  ENG  @0 Lymphatic vessel disease @5 41
C07 06  X  SPA  @0 Linfático patología @5 41
N21       @1 233
N44 01      @1 OTO
N82       @1 OTO

Links toward previous steps (curation, corpus...)

Links to Exploration step

Pascal:12-0305302

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Positive impact of delayed breast reconstruction on breast-cancer treatment-related arm lymphoedema</title>
<author>
<name sortKey="Blanchard, Marie" sort="Blanchard, Marie" uniqKey="Blanchard M" first="Marie" last="Blanchard">Marie Blanchard</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Lymphology, Hôpital Cognacq-Jay, 15, rue Eugène Millon</s1>
<s2>75015 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Arrault, Maria" sort="Arrault, Maria" uniqKey="Arrault M" first="Maria" last="Arrault">Maria Arrault</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Lymphology, Hôpital Cognacq-Jay, 15, rue Eugène Millon</s1>
<s2>75015 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Vignes, Stephane" sort="Vignes, Stephane" uniqKey="Vignes S" first="Stephane" last="Vignes">Stephane Vignes</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Lymphology, Hôpital Cognacq-Jay, 15, rue Eugène Millon</s1>
<s2>75015 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">12-0305302</idno>
<date when="2012">2012</date>
<idno type="stanalyst">PASCAL 12-0305302 INIST</idno>
<idno type="RBID">Pascal:12-0305302</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000081</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000876</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Positive impact of delayed breast reconstruction on breast-cancer treatment-related arm lymphoedema</title>
<author>
<name sortKey="Blanchard, Marie" sort="Blanchard, Marie" uniqKey="Blanchard M" first="Marie" last="Blanchard">Marie Blanchard</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Lymphology, Hôpital Cognacq-Jay, 15, rue Eugène Millon</s1>
<s2>75015 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Arrault, Maria" sort="Arrault, Maria" uniqKey="Arrault M" first="Maria" last="Arrault">Maria Arrault</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Lymphology, Hôpital Cognacq-Jay, 15, rue Eugène Millon</s1>
<s2>75015 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Vignes, Stephane" sort="Vignes, Stephane" uniqKey="Vignes S" first="Stephane" last="Vignes">Stephane Vignes</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Lymphology, Hôpital Cognacq-Jay, 15, rue Eugène Millon</s1>
<s2>75015 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Journal of plastic, reconstructive & aesthetic surgery </title>
<idno type="ISSN">1748-6815</idno>
<imprint>
<date when="2012">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Journal of plastic, reconstructive & aesthetic surgery </title>
<idno type="ISSN">1748-6815</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Arm</term>
<term>Breast</term>
<term>Breast cancer</term>
<term>Lymphedema</term>
<term>Plasty</term>
<term>Surgery</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Cancer du sein</term>
<term>Lymphoedème</term>
<term>Plastie</term>
<term>Traitement</term>
<term>Chirurgie</term>
<term>Sein</term>
<term>Bras</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Chirurgie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Background: The study aims to determine the impact of delayed breast reconstruction on women with breast-cancer treatment-related lymphoedema after mastectomy. Methods: Twenty women with breast-cancer treatment-related arm lymphoedema prospectively requesting breast reconstruction were included between January 2002 and June 2009. Lymphoedema volume was calculated for each 5-cm segment using the formula for a truncated cone. Results: Three patients underwent transverse rectus abdominis myocutaneous flap reconstruction, five received pedicled latissimus dorsi myocutaneous flaps associated with a breast implant and 12 a breast implant (silicone) alone. Median lymphoedema duration at the time of breast reconstruction was 21 (interquartile range (IQR): 17-34) months. Breast reconstruction was done a median of 30 (IQR: 23-56) months after mastectomy. The median lymphoedema volume at medians of 5 (244 ml, IQR: 159-435) and 22 months (235 ml, IQR: 146-361) of follow-up after reconstruction compared to that measured 6 months before breast reconstruction of 378 ml (IQR: 261-459) were significantly lower (p < 0.02 for both). Specific lymphoedema treatment, unchanged during the study, included manual lymph drainage for all women, elastic sleeves for 19 and low-stretch bandages for 14. Conclusion: Delayed breast reconstruction is feasible for women who have developed lymphoedema after mastectomy for breast cancer. Further studies are needed to compare the different breast-reconstruction techniques and to determine their ideal timing (immediate or delayed).</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>1748-6815</s0>
</fA01>
<fA05>
<s2>65</s2>
</fA05>
<fA06>
<s2>8</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Positive impact of delayed breast reconstruction on breast-cancer treatment-related arm lymphoedema</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>BLANCHARD (Marie)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>ARRAULT (Maria)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>VIGNES (Stephane)</s1>
</fA11>
<fA14 i1="01">
<s1>Department of Lymphology, Hôpital Cognacq-Jay, 15, rue Eugène Millon</s1>
<s2>75015 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</fA14>
<fA20>
<s1>1060-1063</s1>
</fA20>
<fA21>
<s1>2012</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>11042</s2>
<s5>354000506642430090</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2012 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>12 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>12-0305302</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Journal of plastic, reconstructive & aesthetic surgery </s0>
</fA64>
<fA66 i1="01">
<s0>GBR</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>Background: The study aims to determine the impact of delayed breast reconstruction on women with breast-cancer treatment-related lymphoedema after mastectomy. Methods: Twenty women with breast-cancer treatment-related arm lymphoedema prospectively requesting breast reconstruction were included between January 2002 and June 2009. Lymphoedema volume was calculated for each 5-cm segment using the formula for a truncated cone. Results: Three patients underwent transverse rectus abdominis myocutaneous flap reconstruction, five received pedicled latissimus dorsi myocutaneous flaps associated with a breast implant and 12 a breast implant (silicone) alone. Median lymphoedema duration at the time of breast reconstruction was 21 (interquartile range (IQR): 17-34) months. Breast reconstruction was done a median of 30 (IQR: 23-56) months after mastectomy. The median lymphoedema volume at medians of 5 (244 ml, IQR: 159-435) and 22 months (235 ml, IQR: 146-361) of follow-up after reconstruction compared to that measured 6 months before breast reconstruction of 378 ml (IQR: 261-459) were significantly lower (p < 0.02 for both). Specific lymphoedema treatment, unchanged during the study, included manual lymph drainage for all women, elastic sleeves for 19 and low-stretch bandages for 14. Conclusion: Delayed breast reconstruction is feasible for women who have developed lymphoedema after mastectomy for breast cancer. Further studies are needed to compare the different breast-reconstruction techniques and to determine their ideal timing (immediate or delayed).</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B25</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>002B20E02</s0>
</fC02>
<fC02 i1="03" i2="X">
<s0>002B12B04</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Cancer du sein</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Breast cancer</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Cáncer del pecho</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Lymphoedème</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Lymphedema</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Linfedema</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Plastie</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Plasty</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Plastia</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Traitement</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Treatment</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Tratamiento</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Chirurgie</s0>
<s5>06</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Surgery</s0>
<s5>06</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Cirugía</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Sein</s0>
<s5>07</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Breast</s0>
<s5>07</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Seno</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Bras</s0>
<s5>08</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Arm</s0>
<s5>08</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Brazo</s0>
<s5>08</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Tumeur maligne</s0>
<s2>NM</s2>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Malignant tumor</s0>
<s2>NM</s2>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Tumor maligno</s0>
<s2>NM</s2>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Cancer</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Cancer</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Cáncer</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Pathologie de la glande mammaire</s0>
<s2>NM</s2>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Mammary gland diseases</s0>
<s2>NM</s2>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Glándula mamaria patología</s0>
<s2>NM</s2>
<s5>38</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Pathologie du sein</s0>
<s2>NM</s2>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Breast disease</s0>
<s2>NM</s2>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Seno patología</s0>
<s2>NM</s2>
<s5>39</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Pathologie de l'appareil circulatoire</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Cardiovascular disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Aparato circulatorio patología</s0>
<s5>40</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE">
<s0>Pathologie des vaisseaux lymphatiques</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG">
<s0>Lymphatic vessel disease</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA">
<s0>Linfático patología</s0>
<s5>41</s5>
</fC07>
<fN21>
<s1>233</s1>
</fN21>
<fN44 i1="01">
<s1>OTO</s1>
</fN44>
<fN82>
<s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000876 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000876 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:12-0305302
   |texte=   Positive impact of delayed breast reconstruction on breast-cancer treatment-related arm lymphoedema
}}
Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024